Cutler Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Hold |
0
| – | – | – | 1569 |
|
2023
Q4 | – | Sell |
-50
| Closed | – | – | 1791 |
|
2023
Q3 | $0 | Sell |
50
-1,150
| -96% | – | ﹤0.01% | 1834 |
|
2023
Q2 | $17K | Buy |
1,200
+100
| +9% | +$1.42K | ﹤0.01% | 865 |
|
2023
Q1 | $7K | Buy |
1,100
+700
| +175% | +$4.46K | ﹤0.01% | 1072 |
|
2022
Q4 | $4K | Hold |
400
| – | – | ﹤0.01% | 1471 |
|
2022
Q3 | $4K | Sell |
400
-200
| -33% | -$2K | ﹤0.01% | 1611 |
|
2022
Q2 | $5K | Hold |
600
| – | – | ﹤0.01% | 1536 |
|
2022
Q1 | $8K | Hold |
600
| – | – | ﹤0.01% | 1595 |
|
2021
Q4 | $11K | Hold |
600
| – | – | ﹤0.01% | 1646 |
|
2021
Q3 | $19K | Sell |
600
-100
| -14% | -$3.17K | ﹤0.01% | 1540 |
|
2021
Q2 | $23K | Hold |
700
| – | – | ﹤0.01% | 1500 |
|
2021
Q1 | $26K | Buy |
+700
| New | +$26K | ﹤0.01% | 1388 |
|
2020
Q2 | – | Sell |
-400
| Closed | -$10K | – | 1957 |
|
2020
Q1 | $10K | Buy |
+400
| New | +$10K | ﹤0.01% | 1125 |
|